|
1
|
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
|
Lancet
|
2009
|
3.16
|
|
2
|
Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.
|
J Bone Miner Res
|
2007
|
1.16
|
|
3
|
Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma.
|
J Aerosol Med
|
2005
|
0.75
|